Skip to main content
SpringerLink
Log in

HCV genotypes in patients with chronic hepatitis C in Croatia

  • Brief Report
  • Published:
Infection Aims and scope Submit manuscript

Summary

The determination of hepatitis C virus (HCV) genotype is an important epidemiological parameter in patients with chronic hepatitis C, while its clinical significance is still a matter of debate. The HCV genotypes in a group of 203 Croatian patients with chronic hepatitis C were examined. Genotypes were correlated to different risk factors, age, duration of the disease, liver histology activity and level of viremia. HCV-RNA was detected in each serum by means of reverse transcription PCR. Genotypes were determined from the amplificate by reverse hybridization in a line probe assay. The level of viremia was assessed by branched DNA (bDNA) signal amplification. The most common genotype was 1b (61.1% of patients), followed by 3a (26.1%), and 1a (10.8%). Other genotypes such as 2a and 4 were only rarely found in our patients (2%). Genotype 1b was most commonly acquired via blood transfusion, while genotype 3a was strongly related to intravenous drug use. Genotype 1b was associated with older age (mean 42.6 vs 29.3 years), longer duration of the disease (mean 6.0 vs 3.5 years), higher histologic activity score (mean 13.2 vs 10.6) and higher viremia (mean 9.06 vs 5.93 Meq/ml) at statistically significant levels (p<0.001) when compared to genotype 3a. The prevalence of HCV genotypes follows the patterns of southeastern European countries, except for a lower prevalence ofgenotype 2. The observation that genotype 1b is associated with higher viremia and more severe liver injury is confirmed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Nizar, N. Z., Pressing, D. H.: Hepatitis C genotypes: current trends and future implications. Mayo Clin. Proc. 71 (1996) 458–462.

    Google Scholar 

  2. Yano, M., Kumadu, H., Kage, M., Ikeda, K., Shimamatsu, K., Inque, O., Hashimoto, E., Lefkowitch, J. H., Ludwig, J., Okuda, K.: The long term pathological evolution of chronic hepatitis C. Hepatology 23 (1996) 1334–1340.

    Article  PubMed  CAS  Google Scholar 

  3. Simmonds, P.: Variability of hepatitis C virus. Hepatology 21 (1995) 570–583.

    PubMed  CAS  Google Scholar 

  4. Simmonds, P., Alberti, A., Alter, H. J., Bonino, F., Bradley, D. W., Brechot, C., Brouwer, J. T., Chan, S. W., Chayama, K., Cjen, D. S., Choo, Q. L., Colombo, H., Cuypers, T. M., Date, T., Dusheiko, G. M., Esteban, J. I., Fay, O., Hadziyannis, S. J., Han, J., Hatzakis, A., Holmes, E. C., Hotta, H., Houghton, M.: A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 19 (1994) 1321–1324.

    PubMed  CAS  Google Scholar 

  5. Pozzato, G., Moretti, M., Croce, L. S., Sasso, F., Kaneko, S., Unoura, K., Kobayashi, K., Crovatto, M., Santini, G., Tiribelli, C.: Interferon therapy in chronic hepatitis C: evidence of different outcome with respect to different viral strains. J. Med. Virol. 45 (1995) 445–450.

    Article  PubMed  CAS  Google Scholar 

  6. Silini, E., Bono, F., Cividini, A., Cerino, A., Bruno, S., Rossi, G., Belloni, G., Brugnetti, B., Civardi, E., Salvaneschi, L., Mondelli, M.: Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities. Hepatology 21 (1995) 291–297.

    Google Scholar 

  7. Kasahara, A., Hayashi, N., Hiramatsu, N., Oshita, N., Hagiwara, H., Katayama, K., Kato, M., Masuzawa, M., Yoshihara, H., Kishida, Y., Shimizu, Y, Inoue, A., Fusamoto, H., Kamada, T.: Ability of prolonged interferon treatment to suppress relapse after cessation of therapy in patients with chronic hepatitis C: a multicenter randomized controlled trial. Hepatology 21 (1995) 291–297.

    PubMed  CAS  Google Scholar 

  8. Kobayashi, M., Tanaka, E., Sodeyama, T., Urushihara, A., Matsumoto, A., Kiyosawa, K.: The natural course of chronic hepatitis C: a comparison between patients with genotypes 1 and 2 hepatitis C viruses. Hepatology 23 (1996) 695–699.

    Article  PubMed  CAS  Google Scholar 

  9. Nosbaum, J. B., Pol, S., Nalpas, B., Landais, P., Bertholet, P., Brechot, C.: Hepatitis C virus type 1b (II) infection in France and Italy. Ann. Intern. Med. 122 (1995) 161–166.

    Google Scholar 

  10. Smith, D. B., Davidson, F., Yap, P. L., Brown, H., Kolberg, J., Detmer, J., Urdea, M., Simmonds, P.: Levels of hepatitis C virus in blood donors infected with differential viral genotypes. J. Infect. Dis. 173 (1996) 727–730.

    PubMed  CAS  Google Scholar 

  11. Hawkins, A., Davidson, F., Simmonds, P.: Comparison of plasma virus loads among individuals infected with hepatitis C virus (HCV) genotypes 1, 2, and 3 by quantiplex HCV RNA assay versions 1 and 2, Roche Monitor Assay and an in-house limiting dilution method. J. Clin. Microbiol. 35 (1997) 187–192.

    PubMed  CAS  Google Scholar 

  12. Martinot-Peignoux, M., Marcellin, P., Poatou, M., Castelnau, C., Boyer, N., Poliquin, M., Degott, C., Descombes, I., Breton, V., Milotova, V., Benhamou, J. P., Erlinger, S.: Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C. Hepatology 22 (1996) 1050–1055.

    Article  Google Scholar 

  13. Magrin, S., Craxi, A., Fabiano, C., Marino, L., Fiorentino, G., Lo Iacono, O., Volpes, R., Di Marco, V., Almasio, P., Urdea, M. S., Wilber, J. C., Bonura, C., Gianguzza, F., Capursi, V., Filiberti, S., Stuyver, L., Pagliano, L.: HCV viremia is more important than genotype as a predictor of response to interferon in Sicily (southern Italy). J. Hepatol. 25 (1996) 583–590.

    Article  PubMed  CAS  Google Scholar 

  14. Dusheiko, G., Schmilowitz-Weiss, H., Brown, D., McOmish, F., Yap, F. L., Sherlock, S., McIntyre, N., Simmonds, P.: Hepatitis C virus genotypes: an investigation of type specific differences in geographic origin and disease. Hepatology 19 (1994) 13–18.

    PubMed  CAS  Google Scholar 

  15. McOmish, F., Yap, P. I., Dow, B. C., Follett, C., Seed, C., Keller, A. J., Cobain, T. J., Krusius, R., Kolho, E., Naukarinnen, R., Lin, C., Lai, C., Leong, S., Medgyesi, G. A., Hejjas, M., Kiyokawa, H., Fukada, K., Cuypers, T., Saeed, A. A., Lin, M., Simmonds, P.: Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey. J. Clin. Microbiol. 32 (1994) 884–892.

    PubMed  CAS  Google Scholar 

  16. Okamoto, H., Sugiyama, Y., Okada, S., Kurai, K., Akahane, Y., Sugai, Y., Tanaka, T., Sato, K., Tsuda, F., Miyakawa, M., Mayumi, M.: Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J. Gen. Virol. 73 (1992) 673–679.

    PubMed  CAS  Google Scholar 

  17. Shey, S., Widell, A., Foberg, U., Fryden, A.: HCV genotypes in Swedish blood donors as correlated to epidemiology, liver disease and hepatitis C virus antibody profile. Infection 23 (1995) 253–262.

    Article  Google Scholar 

  18. Tokita, H., Okamoto, H., Tsuda, F., Song, P., Nakata, S., Chosa, T., Izuka, H., Mishiro, S., Miyakawa, Y., Mayumi, M.: Hepatitis C virus variants from Vietnam are classifiable into the seventh, eighth, and ninth major genetic groups. Proc. Natl. Acad. Sci. USA 91 (1994) 11022–11026.

    Article  PubMed  CAS  Google Scholar 

  19. Doi, H., Apichartpiyakul, C., Ohba, K.-I., Mizokami, M., Hotta, H.: Hepatitis C virus (HCV) subtype prevalence in Chiang Mai, Thailand, and identification of novel subtypes of HCV major type 6. J. Clin. Microbiol. 34 (1996) 569–574.

    PubMed  CAS  Google Scholar 

  20. Maggi, F., Vatteroni, M. L., Fornai, C., Morrica, A., Giorgi, M., Bendinelli, M., Pistello, M.: Subtype 2c of hepatitis C virus is highly prevalent in Italy and is heterogenous in the NS5A Region. J. Clin. Microbiol. 35 (1997) 161–164.

    PubMed  CAS  Google Scholar 

  21. Pawlotsky, J. M., Tsakiris, L., Roudot-Thoraval, F., Pellet, C., Stuyver, L., Duval, J., Dhumeaux, D.: Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C. J. Infect. Dis. 171 (1995) 1607–1610.

    PubMed  CAS  Google Scholar 

  22. Mihaljević, I., Feldbauer, J., Delalija, M., Grgičevié, D.: Antibodies to hepatitis C virus in Croatian blood donors and polytransfused patients. Vox Sang. 63 (1992) 236.

    PubMed  Google Scholar 

  23. Knodell, R. G., Ishak, K. G., Black, W. C., Chen, T. S., Craig, T. R., Kaplowitz, N.: Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1 (1981) 431–435.

    Article  PubMed  CAS  Google Scholar 

  24. Desmet, V. J., Gerber, M., Hoofnagle, J. H., Manns, M., Scheuer, P. J.: Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 19 (1994) 1513–1520.

    Article  PubMed  CAS  Google Scholar 

  25. Andonov, A., Chaudary, R. K.: Subtyping of hepatitis C virus isolates by a line probe assay using hybridization. J. Clin. Microbiol. 33 (1995) 254–256.

    PubMed  CAS  Google Scholar 

  26. Stuyver, L., Wyseur, A., van Arnham, W., Hernandez, F., Maertens, G.: Second-generation line probe assay for hepatitis C virus genotyping. J. Clin. Microbiol. 34 (1996) 2259–2266.

    PubMed  CAS  Google Scholar 

  27. Detmer, J., Lagier, R., Flynn, J., Zayati, C., Kolberg, J., Collins, M., Urdea, M., Sanchez-Pescador, R.: Accurate quantification of hepatitis C virus (HCV) RNA from all HCV genotypes by using branched-DNA technology. J. Clin. Microbiol. 34 (1996) 901–907.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Molecular Laboratory, University Hospital for Infectious Diseases, Mirogojska 8, HR-10 000, Zagreb, Croatia

    A. Vince M. D., N. Kutela M. D. & M. Radovani M. D.

  2. Dept. of Hepatology, University Hospital for Infectious Diseases, Mirogojska 8, HR-10 000, Zagreb, Croatia

    D. Palmović M. D.

  3. Dept. of Laboratory Medicine, University Hospital for Infectious Diseases, Mirogojska 8, HR-10 000, Zagreb, Croatia

    T. Jeren M. D.

  4. Public Health School, Zagreb, Croatia

    Z. Sonicky M. D.

Authors
  1. A. Vince M. D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. Palmović M. D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. N. Kutela M. D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Z. Sonicky M. D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. T. Jeren M. D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. Radovani M. D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vince, A., Palmović, D., Kutela, N. et al. HCV genotypes in patients with chronic hepatitis C in Croatia. Infection 26, 173–177 (1998). https://doi.org/10.1007/BF02771846

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02771846

Keywords

Search

Navigation